For the first time, you can use an insulin pen without sacrificing data and decision support. The InPen system enhances how you manage MDI because it tracks your data in real time and offers personalized dosing recommendations.
Fill in the InPen form above
We'll contact you about your insurance coverage
We’ll get a prescription† from your healthcare provider for InPen
Pick up your InPen and supplies from your local pharmacy or via mail order
InPen is the only smart insulin pen system combining a reusable Bluetooth®-enabled insulin pen with an intuitive mobile app to help people with diabetes take the right amount of insulin at the right time.
The InPen is the only FDA-cleared smart3 insulin pen that combines the freedom of Bluetooth® technology and intelligence through an easy to use smartphone app, helping people administer correction and meal-time insulin doses.
InPen is a prescription-only device. Eligible patients with commercial insurance may pay as little as $35 per prescribed InPen. Each InPen is reusable for one year. Terms and conditions apply. Learn more.
Yes, you can pair as many InPens as you need to the app. This enables the flexibility for you to have one InPen at home and another at work or school.
Note: Make sure your paired device is within range of your InPen when you dose. Your InPen app will automatically sync doses from all paired InPen(s) when within range.
* Data may not appear or be delayed in certain instances, including when there is no internet connection.
1. Guardian™ Connect system SSED, page 19, Table 5. 90.5% Glucose Correct Detection Rate without Predictive Alerts at both 15 and 30 minutes when worn on the abdomen.
2. Guardian™ Connect system SSED, page 19, Table 5. 98.5% Glucose Correct Detection Rate based on Predictive Alerts at 30 minutes when worn on the abdomen.
3. Smart insulin pens connect to a mobile app to provide dosing calculations, reminders and CGM system integration.
Each InPen is reusable for one year. Offer available to eligible patients with commercial insurance. Terms and conditions apply. Learn more.
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.
Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.
Important Safety Information: InPen™
The InPen™ is a home- use reusable pen injector for single- patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self- injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient- specific criteria and targets. The InPen™ requires a prescription. For additional product and safety information, please consult the Instructions for Use and bit.ly/InPenRisks.com.
Rx only. Under age 7 requires supervision of an adult caregiver. User interaction, compatible device, proper pairing and settings required. See http://bit.ly/InPenSafety
Important Safety Information: i-Port Advance™ injection port
i-Port Advance™ injection port is indicated for patients who administer or receive multiple daily subcutaneous injections of physician prescribed medications, including insulin. The device may remain in place for up to 72 hours to accommodate multiple injections without the discomfort of additional needle sticks. i-Port Advance™ injection port may be used on a wide range of patients, including adults and children. For more, please see important safety information.